Wheeler P G, Smith T, Golindano C, Alam A N, Wilkinson S P, Edmonds C J, Williams R
Gut. 1977 Sep;18(9):683-7. doi: 10.1136/gut.18.9.683.
Total body potassium (40K) and leucocyte potassium measurements were carried out on 19 patients with stable but decompensated cirrhosis maintained on diuretics for previous ascites. Of 13 patients receiving spironolactone alone none had a total body potassium below the expected lower limit of normal, whereas, of six receiving additional frusemide, two had low values. The results for leucocyte potassium were in agreement and simultaneous measurements of leucocyte magnesium showed a close correlation, those with intracellular potassium depletion also having magnesium depletion. One such patient was treated with magnesium supplements without effect on the potassium, although intracellular magnesium was improved. It is concluded that spironolactone alone is the treatment of choice in the maintenance management of such patients; that additional potassium would be unnecessary; and that additional frusemide should be avoided if possible.
对19例稳定但失代偿性肝硬化患者进行了全身钾(40K)和白细胞钾测量,这些患者因既往腹水而持续使用利尿剂。在仅接受螺内酯治疗的13例患者中,无一例全身钾低于预期正常下限,而在另外6例接受速尿治疗的患者中,有2例钾值较低。白细胞钾的结果与之相符,同时测量白细胞镁显示两者密切相关,细胞内钾缺乏的患者也有镁缺乏。其中1例患者补充镁后对钾无影响,尽管细胞内镁有所改善。结论是,对于此类患者的维持治疗,单独使用螺内酯是首选治疗方法;无需额外补充钾;如果可能应避免额外使用速尿。